Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.8300 (4.88%) ($98.1200 - $102.8100) on Fri. Mar. 11, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 65 | Latest Price | $101.8300(4.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 3.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.42% in a week (0% probabilities). VIXM(-16%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
5 Day Moving Average | $99.97(1.86%) | 10 Day Moving Average | $98.37(3.52%) | 20 Day Moving Average | $95.06(7.12%) | To recent high | -9% | To recent low | 18.7% | Market Cap | $1.637b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |